Immunic, Inc. (IMUX)
0.94
-0.03
(-3.56%)
USD |
NASDAQ |
Feb 20, 16:00
0.925
-0.02
(-1.60%)
After-Hours: 20:00
Immunic Total Liabilities (Quarterly) : 30.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioRestorative Therapies, Inc. | 3.436M |
| Quince Therapeutics, Inc. | 108.84M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Agenus, Inc. | 514.76M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.70M |
| Shareholders Equity (Quarterly) | 10.50M |
| Debt to Equity Ratio | 0.0754 |
| Current Ratio | 1.306 |
| Net Debt Paydown Yield | 0.04% |